Decreased lysyl oxidase-like 2 expression in mid-dermal elastolysis

Area of Science:

• Dermatology
• Molecular Biology
• Biochemistry

Background:

• Mid-dermal elastolysis (MDE) is a rare connective tissue disorder characterized by selective loss of elastic fibers in the mid-dermis.
• The exact causes of MDE remain largely unknown.
• This study investigates the expression of lysyl oxidase-like (LOXL) proteins and matrix metalloproteinases (MMPs) in MDE.

Observation:

• Researchers analyzed lesional and non-lesional skin from a patient with the reticular variant of MDE.
• Gene expression (mRNA) and protein levels of MMP2, MMP7, MMP9, LOXL1, LOXL2, and LOXL3 were examined using RT-PCR and immunohistochemistry.
• Significant findings included decreased LOXL2 mRNA and massively increased MMP9 mRNA in lesional skin compared to healthy skin.

Findings:

• LOXL1 and LOXL3 mRNA levels were comparable between lesional and healthy skin.
• LOXL2 mRNA expression was significantly reduced in lesional skin.
• MMP9 mRNA expression was markedly elevated in lesional skin, with immunohistochemistry confirming altered LOXL2 and MMP9 expression.

Implications:

• The findings suggest a dual mechanism in MDE pathogenesis: increased elastolytic activity (via MMP9 up-regulation) and impaired elastin renewal (due to reduced LOXL expression).
• Further research into the LOX family, fibulins, fibrillins, and desmosines is warranted for a comprehensive understanding of MDE.
• These insights could pave the way for novel diagnostic markers and therapeutic strategies for MDE.